Advertisement
Advertisement
U.S. markets close in 3 hours 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Aquestive Therapeutics, Inc. (AQST)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.5300+0.0300 (+2.00%)
As of 11:46AM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/29/2023
Current
6/30/20233/31/202312/31/20229/30/20226/30/2022
Market Cap (intraday)
100.09M92.27M63.69M48.85M62.42M31.44M
Enterprise Value
122.77M113.81M93.91M85.29M100.71M73.58M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.822.011.170.850.980.49
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue
2.648.608.437.988.795.55
Enterprise Value/EBITDA
-9.89-30.029.83-8.01-12.20-6.10

Trading Information

Stock Price History

Beta (5Y Monthly) 2.62
52-Week Change 328.21%
S&P500 52-Week Change 319.92%
52 Week High 32.6900
52 Week Low 30.7200
50-Day Moving Average 31.7434
200-Day Moving Average 31.4260

Share Statistics

Avg Vol (3 month) 3323.27k
Avg Vol (10 day) 3305.87k
Shares Outstanding 566.73M
Implied Shares Outstanding 666.73M
Float 858.19M
% Held by Insiders 15.64%
% Held by Institutions 126.77%
Shares Short (Sep 14, 2023) 41.85M
Short Ratio (Sep 14, 2023) 49.27
Short % of Float (Sep 14, 2023) 43.57%
Short % of Shares Outstanding (Sep 14, 2023) 42.77%
Shares Short (prior month Aug 14, 2023) 41.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin -48.61%
Operating Margin (ttm)-61.01%

Management Effectiveness

Return on Assets (ttm)-31.31%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)46.52M
Revenue Per Share (ttm)0.84
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)28.29M
EBITDA -26.61M
Net Income Avi to Common (ttm)-22.61M
Diluted EPS (ttm)-0.4000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.44M
Total Cash Per Share (mrq)0.36
Total Debt (mrq)45.12M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.03
Book Value Per Share (mrq)-1.73

Cash Flow Statement

Operating Cash Flow (ttm)12.16M
Levered Free Cash Flow (ttm)-11.84M
Advertisement
Advertisement